The chromatin-associated enzyme PARP1, which is one of the core directors of DNA repair and involved in tumorigenesis pathways, was over-expressed in many of the cancer types, such as breast, uterine, ovarian, colorectal, lung, leukemia, and lymphomas at the mRNA and/or protein levels [83]. This evidence concerns the gene PARP1 and lymphoma.